Caxton Associates (UK)’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.35M Buy
39,615
+15,177
+62% +$1.22M 0.06% 144
2026
Q1
$1.73M Buy
24,438
+14,844
+155% +$1.11M 0.04% 253
2025
Q4
$757K Buy
9,594
+5,769
+151% +$457K 0.01% 414
2025
Q3
$315K Hold
3,825
0.01% 542
2025
Q2
$308K Hold
3,825
0.01% 546
2025
Q1
$307K Buy
+3,825
New +$318K 0.01% 623

Other funds holding MET

Caxton Associates (UK)'s MET Position: Q2 2026 in Review

Caxton Associates (UK) increased its MetLife (MET) stake by 62% in Q2 2026, buying an estimated $1.22M and bringing the position to 39,615 shares worth $3.35M. The position accounts for 0.06% of the portfolio, ranked #144.

Caxton Associates (UK) first reported a position in MET in Q1 2025 and has held it in 6 quarters since. 1,445 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Caxton Associates (UK) held 39,615 shares of MetLife worth $3.35M as of Q2 2026.
  • Caxton Associates (UK) bought 15,177 MetLife shares in Q2 2026, an estimated $1.22M.
  • MetLife made up 0.06% of Caxton Associates (UK)'s portfolio in Q2 2026, its #144 holding.
  • Caxton Associates (UK) first reported a position in MetLife in Q1 2025 and has held it in 6 quarters since.
  • 1,445 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Caxton Associates (UK)'s 13F filing for Q2 2026, filed 14 Aug 2026.